- PCSA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Processa Pharmaceuticals (PCSA) 8-K25 Jan 24NGC-Cap was better tolerated with positive preliminary efficacy results than FDA-approved capecitabineFinancial data
Company Profile